/lex/drugshttp://www.ft.com/rss/lex/drugsFT.com - Lex, Drugs & healthcareen© Copyright The Financial Times Ltd 2008. "FT" and "Financial Times" are trademarks of the Financial Times. See http://www.ft.com/servicestools/help/terms#legal1 for the terms and conditions of reuse.support@ft.comTue, 22 Jul 2008 01:26 BSTThu, 24 Jul 2008 20:47:54 BSTNewspapers15http://news.ft.com/cms/d1f3ce1a-6bbe-11da-bb53-0000779e2340.gif/lex/drugs(PICS-1.1 "http://www.classify.org/safesurf/" L gen true for "http://www.ft.com/" r (SS~~000 1))http://www.ft.com/cms/s/1/6efa26a8-56fb-11dd-916c-000077b07658.htmlhttp://www.ft.com/cms/s/1/6efa26a8-56fb-11dd-916c-000077b07658.htmlMixing up the right dose is any pharmacist's core competence. Roche has underdone it with the cash fix it is offering minority investors in GenentechTue, 22 Jul 2008 01:26 BSThttp://www.ft.com/cms/s/1/21f689da-4bf9-11dd-96bb-000077b07658.htmlhttp://www.ft.com/cms/s/1/21f689da-4bf9-11dd-96bb-000077b07658.htmlPerformance-based deals, or 'earn-outs', could be set to spread to public markets, and on a much bigger scaleMon, 7 Jul 2008 19:56 BSThttp://www.ft.com/cms/s/1/7c4ee254-3792-11dd-aabb-0000779fd2ac.htmlhttp://www.ft.com/cms/s/1/7c4ee254-3792-11dd-aabb-0000779fd2ac.htmlThe proposed sale of Ranbaxy to the Japanese, the largest takeover of a listed Indian company, will be a bitter pill for corporate IndiaWed, 11 Jun 2008 20:02 BSThttp://www.ft.com/cms/s/1/fd780de6-1ad3-11dd-aa67-0000779fd2ac.htmlhttp://www.ft.com/cms/s/1/fd780de6-1ad3-11dd-aa67-0000779fd2ac.htmlThis year a quarter of Reckitt Benckiser's sales, and at least a third of profits, will be made from consumer healthcare – selling branded versions of generic drugs that do not need a prescriptionTue, 6 May 2008 08:15 BSThttp://www.ft.com/cms/s/1/cd4ebe64-11da-11dd-9b49-0000779fd2ac.htmlhttp://www.ft.com/cms/s/1/cd4ebe64-11da-11dd-9b49-0000779fd2ac.htmlThe developed world's bulging waistlines are often lamented. Yet there are some reasons why, rather than discouraging their populations from getting fatter, governments might choose to sit on their hands insteadThu, 24 Apr 2008 20:41 BSThttp://www.ft.com/cms/s/1/446bc492-104b-11dd-b8d6-0000779fd2ac.htmlhttp://www.ft.com/cms/s/1/446bc492-104b-11dd-b8d6-0000779fd2ac.htmlShares in medical technology companies, having lagged broader indices last year, are now enjoying a respite and have edged by nearly 5% this year Tue, 22 Apr 2008 19:54 BSThttp://www.ft.com/cms/s/1/844c35b2-0f77-11dd-8871-0000779fd2ac.htmlhttp://www.ft.com/cms/s/1/844c35b2-0f77-11dd-8871-0000779fd2ac.htmlAfter a weak fourth quarter, the Swiss pharmaceuticals company announced first-quarter net sales and operating profits that significantly exceeded analysts' expectationsMon, 21 Apr 2008 19:21 BST